2019
DOI: 10.1016/j.actbio.2019.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Polyvinylidene fluoride–Hyaluronic acid wound dressing comprised of ionic liquids for controlled drug delivery and dual therapeutic behavior

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(24 citation statements)
references
References 84 publications
(95 reference statements)
0
23
0
Order By: Relevance
“…However, due to the lack of statistic significant results between Etoreat and placebo administration, its further stage of development was suspended. In addition to this example, other dual-active API-ILs have been considered for improving transdermal delivery of analgesic and anti-inflammatory APIs in wound healing [206] Chantereau et al [203] later incorporated NSAID-based ILs also into BC membranes envisaging their use in transdermal drug delivery systems. These [Ch][NSAID] ILs allowed for increasing up to 100-fold the solubility of the respective NSAID precursors (ibuprofen, naproxen and ketoprofen) in aqueous media.…”
Section: Topical and Transdermal Drug Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…However, due to the lack of statistic significant results between Etoreat and placebo administration, its further stage of development was suspended. In addition to this example, other dual-active API-ILs have been considered for improving transdermal delivery of analgesic and anti-inflammatory APIs in wound healing [206] Chantereau et al [203] later incorporated NSAID-based ILs also into BC membranes envisaging their use in transdermal drug delivery systems. These [Ch][NSAID] ILs allowed for increasing up to 100-fold the solubility of the respective NSAID precursors (ibuprofen, naproxen and ketoprofen) in aqueous media.…”
Section: Topical and Transdermal Drug Deliverymentioning
confidence: 99%
“…However, due to the lack of statistic significant results between Etoreat and placebo administration, its further stage of development was suspended. In addition to this example, other dual-active API-ILs have been considered for improving transdermal delivery of analgesic and anti-inflammatory APIs in wound healing [206]. Lidocainium naproxen ([Lid][Nap]), [Lid][Ibu], and lidocainium diclofenac ([Lid][Dicl]) were synthesized, which resulted in liquid mixtures at room temperature.…”
Section: Topical and Transdermal Drug Deliverymentioning
confidence: 99%
“…Cell adhesion of fibroblasts on HA-based membrane surfaces and cell viability evaluation confirmed enhanced viability and adhesion of fibroblasts on the membranes. Healing assay evaluated with fibroblasts demonstrated that the bilayer membranes containing API-ILs are not detrimental to wound healing [ 85 ].…”
Section: Bioactive Agents Loaded Hyaluronic Acid Scaffoldsmentioning
confidence: 99%
“…Incorporation of lidocaine/NSAIDs-based dual-action ILs into polyvinylidene fluoride/hyaluronic acid-based membranes has also been addressed by Abednejad et al, who found (i) an up to 470-fold enhancement of the water solubility of the ILs as compared to the free APIs, (ii) improved release of the APIs from the IL-loaded membranes, (iii) suitability of the IL-loaded membranes for use as wound-dressings, (iv) enhanced membrane adhesion and viability of membrane-adhered fibroblasts, and (v) anti-inflammatory activity similar to that of the free APIs [ 139 ].…”
Section: Ionic Liquid-based Approaches In Dermal and Transdermal Drug Deliverymentioning
confidence: 99%